Evidence map›Paper›PMID 34609164›Full record

ArticlemSystems2021

Novel Drivers of Virulence in Clostridioides difficile Identified via Context-Specific Metabolic Network Analysis.

Matthew L Jenior, Jhansi L Leslie, Deborah A Powers, Elizabeth M Garrett, Kimberly A Walker, Mary E Dickenson, William A Petri, Rita Tamayo, Jason A Papin

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. A programmed reset mechanism primesScience advances · 2026
    Article
  2. Phase variable colony morphotypes ofInfection and immunity · 2026
    Article
  3. Journal of bacteriology · 2026
    Article
  4. Phase variable colony morphotypes ofbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Unravelling three-way interactions betweenJournal of medical microbiology · 2025
    Review
  8. Article
  9. bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. mSphere · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Matthew L JeniorDepartment of Biomedical Engineering, University of Virginiagrid.27755.32, Charlottesville, Virginia, USA.ORCID 0000-0003-1884-3543
Jhansi L LeslieDepartment of Medicine, Division of Infectious Diseases & International Health, University of Virginiagrid.27755.32, Charlottesville, Virginia, USA.ORCID 0000-0001-5600-210X
Deborah A PowersDepartment of Biochemistry & Molecular Genetics, University of Virginiagrid.27755.32, Charlottesville, Virginia, USA.
Elizabeth M GarrettDepartment of Microbiology & Immunology, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Kimberly A WalkerDepartment of Microbiology & Immunology, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Mary E DickensonDepartment of Biomedical Engineering, University of Virginiagrid.27755.32, Charlottesville, Virginia, USA.
William A PetriDepartment of Medicine, Division of Infectious Diseases & International Health, University of Virginiagrid.27755.32, Charlottesville, Virginia, USA.ORCID 0000-0002-7268-1218
Rita TamayoDepartment of Microbiology & Immunology, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.ORCID 0000-0002-3745-3316
Jason A PapinDepartment of Biomedical Engineering, University of Virginiagrid.27755.32, Charlottesville, Virginia, USA.ORCID 0000-0002-2769-5805
University of North Carolina at Chapel Hill · USUniversity of Virginia · USUniversity of Virginia Health System · US

Funding

INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
Role of Th17 in Severe and Recurrent C. difficile InfectionR01AI152477 · NIAID · UNIVERSITY OF VIRGINIA · PI PETRI, WILLIAM A, RAMAKRISHNAN, GIRIJA · 2020 to 2025
$7.1M
Role of Type 2 Immunity in Innate Protection from C. difficileR01AI124214 · NIAID · UNIVERSITY OF VIRGINIA · PI William A Petri · 2016 to 2026
$5.4M
Global regulation in Clostridium difficile via phase variation of cyclic diguanylate signalingR01AI143638 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAMAYO, RITA · 2019 to 2023
$2.5M
Systems biology of microbe-mediated glucosinolate bioconversion in inflammatory bowel diseaseR01AT010253 · NCCIH · UNIVERSITY OF VIRGINIA · PI PAPIN, JASON · 2018 to 2021
$2.0M
The role of the Western diet in increasing severity of Clostridium difficile infectionF32DK124048 · NIDDK · UNIVERSITY OF VIRGINIA · PI LESLIE, JHANSI LAKSHMI MARGARET · 2020 to 2022
$138k
HHS | NIH | National Center for Complementary and Integrative Health (NCCIH) R01AT010253HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI124214HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01Al143638HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) F32DK124048NCCIH NIH HHS R01 AT010253NIAID NIH HHS R01 AI124214NIAID NIH HHS R01 AI143638NIAID NIH HHS R01 AI152477NIAID NIH HHS T32 AI007496NIDDK NIH HHS F32 DK124048
6 · The paper itself

Abstract

The pathogen Clostridioides difficile causes toxin-mediated diarrhea and is the leading cause of hospital-acquired infection in the United States. Due to growing antibiotic resistance and recurrent infection, targeting C. difficile metabolism presents a new approach to combat this infection. Genome-scale metabolic network reconstructions (GENREs) have been used to identify therapeutic targets and uncover properties that determine cellular behaviors. Thus, we constructed C. difficile GENREs for a hypervirulent isolate (strain [str.] R20291) and a historic strain (str. 630), validating both with

Indexed as

Clostridioides difficilemetabolic modelingtranscriptomicsvirulence factors

Identifiers

PMID34609164
PMCPMC8547418
OpenAlexW3203478130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.